With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government ...

The NPPA has extended the price ceiling for orthopaedic knee implants till November 2025 as it reviews industry requests for ...

The NPPA has revised ceiling prices for coronary stents to make life-saving devices more affordable. Hospitals must follow ...

New Delhi: The Union government has fixed the ceiling price of four emergency-use medicines and 37 other drug formulations, which include antibiotics and painkillers. The prices were fixed by the ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

The National Pharmaceutical Pricing Authority (NPPA) has notified price revision of various scheduled drugs and coronary stents, among others in tandem with the 0.65% change in Wholesale Price Index ...